Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. (Q38747496)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 February 2016

Language	Label	Description	Also known as
English	Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.	scientific article published on 24 February 2016

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

Heidi Staudacher

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Kevin Whelan

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

24 February 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Proceedings of the Nutrition Society

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

75

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

306-318

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The impact of irritable bowel syndrome on health-related quality of life

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Colonic responses to gas loads in subgroups of patients with abdominal bloating

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Long-term adenoma recurrence following wide-field endoscopic mucosal resection (WF-EMR) for advanced colonic mucosal neoplasia is infrequent: results and risk factors in 1000 cases from the Australian Colonic EMR (ACE) study.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Effect of nonabsorbed amounts of a fructose-sorbitol mixture on small intestinal transit in healthy volunteers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Abnormal colonic fermentation in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The effects of butyrate enemas on visceral perception in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Anal gas evacuation and colonic microbiota in patients with flatulence: effect of diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Comorbidity in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

A role for the gut microbiota in IBS.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Metabolic activities and probiotic potential of bifidobacteria.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Faecalibacterium prausnitzii and human intestinal health

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Richness of human gut microbiome correlates with metabolic markers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Diversity, stability and resilience of the human gut microbiota

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Diversity of intestinal microbiota in infancy and the risk of allergic disease in childhood.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Linking long-term dietary patterns with gut microbial enterotypes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Exercise and associated dietary extremes impact on gut microbial diversity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The human microbiome: ecosystem resilience and health

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Colonic butyrate- algesic or analgesic?

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Rethinking "enterotypes".

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Enterotypes of the human gut microbiome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

A human gut microbial gene catalogue established by metagenomic sequencing

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

In vitro fermentation profiles, gas production rates, and microbiota modulation as affected by certain fructans, galactooligosaccharides, and polydextrose

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Host-bacterial mutualism in the human intestine

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The human gut microbiome: ecology and recent evolutionary changes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Association between early adverse life events and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Severity in irritable bowel syndrome: a Rome Foundation Working Team report

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Irritable bowel syndrome: an integrated explanatory model for clinical practice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

On the presence of inulin and oligofructose as natural ingredients in the western diet

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Editorial: The importance of systematic reviews and meta-analyses of probiotics and prebiotics.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Consumption of fermented milk product with probiotic modulates brain activity

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Mechanisms and efficacy of dietary FODMAP restriction in IBS.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Peripheral factors in the pathophysiology of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Fiber and functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

21 January 2018

Efficient diagnosis of suspected functional bowel disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Diet rapidly and reproducibly alters the human gut microbiome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Gut microbiota composition correlates with diet and health in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Organic and functional disorders in 2000 gastroenterology outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Gut microbiome of the Hadza hunter-gatherers

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Human gut microbiome viewed across age and geography

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of a food frequency questionnaire to measure intakes of inulin and oligofructose

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of regular consumption of short-chain fructo-oligosaccharides on digestive comfort of subjects with minor functional bowel disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial of oligofructose in the management of irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans.

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0029665116000021

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S0029665116000021

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

release_npfouth4fneildqymmx5kztlmi

1 reference

https://api.fatcat.wiki/v0/release/npfouth4fneildqymmx5kztlmi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26908093%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38747496&oldid=1838753108"